Strength and limitations Although primary and secondary outcomes did not reach statistical significance and the confidence intervals were wide, this paper is methodologically robust and we believe contributes valuable evidence regarding oseltamivir use in obstetric patients with COVID-19.
← all excerpts
Effectiveness of oseltamivir in hospitalised obstetric patients with COVID-19: a retrospective cohort study using a Brazilian national database.
1
—
—